IBDEI0NH ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,10572,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10572,1,3,0)
;;=3^Bipolar & Related Disorder,Other Specified
;;^UTILITY(U,$J,358.3,10572,1,4,0)
;;=4^F31.89
;;^UTILITY(U,$J,358.3,10572,2)
;;=^5003520
;;^UTILITY(U,$J,358.3,10573,0)
;;=F31.9^^42^471^5
;;^UTILITY(U,$J,358.3,10573,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10573,1,3,0)
;;=3^Bipolar & Related Disorder,Unsp
;;^UTILITY(U,$J,358.3,10573,1,4,0)
;;=4^F31.9
;;^UTILITY(U,$J,358.3,10573,2)
;;=^331892
;;^UTILITY(U,$J,358.3,10574,0)
;;=A81.00^^42^472^8
;;^UTILITY(U,$J,358.3,10574,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10574,1,3,0)
;;=3^Creutzfeldt-Jakob Disease,Unspec
;;^UTILITY(U,$J,358.3,10574,1,4,0)
;;=4^A81.00
;;^UTILITY(U,$J,358.3,10574,2)
;;=^5000409
;;^UTILITY(U,$J,358.3,10575,0)
;;=A81.09^^42^472^7
;;^UTILITY(U,$J,358.3,10575,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10575,1,3,0)
;;=3^Creutzfeldt-Jakob Disease,Other
;;^UTILITY(U,$J,358.3,10575,1,4,0)
;;=4^A81.09
;;^UTILITY(U,$J,358.3,10575,2)
;;=^5000410
;;^UTILITY(U,$J,358.3,10576,0)
;;=A81.2^^42^472^73
;;^UTILITY(U,$J,358.3,10576,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10576,1,3,0)
;;=3^Progressive Multifocal Leukoencephalopathy
;;^UTILITY(U,$J,358.3,10576,1,4,0)
;;=4^A81.2
;;^UTILITY(U,$J,358.3,10576,2)
;;=^5000411
;;^UTILITY(U,$J,358.3,10577,0)
;;=F01.50^^42^472^47
;;^UTILITY(U,$J,358.3,10577,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10577,1,3,0)
;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/o Behav Disturb
;;^UTILITY(U,$J,358.3,10577,1,4,0)
;;=4^F01.50
;;^UTILITY(U,$J,358.3,10577,2)
;;=^5003046
;;^UTILITY(U,$J,358.3,10578,0)
;;=F01.51^^42^472^48
;;^UTILITY(U,$J,358.3,10578,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10578,1,3,0)
;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/ Behav Disturb
;;^UTILITY(U,$J,358.3,10578,1,4,0)
;;=4^F01.51
;;^UTILITY(U,$J,358.3,10578,2)
;;=^5003047
;;^UTILITY(U,$J,358.3,10579,0)
;;=F02.80^^42^472^35
;;^UTILITY(U,$J,358.3,10579,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10579,1,3,0)
;;=3^Major Neurocog D/O d/t Poss ALZHEIMER'S DISEASE w/o Behav Disturb
;;^UTILITY(U,$J,358.3,10579,1,4,0)
;;=4^F02.80
;;^UTILITY(U,$J,358.3,10579,2)
;;=^5003048
;;^UTILITY(U,$J,358.3,10580,0)
;;=F02.81^^42^472^36
;;^UTILITY(U,$J,358.3,10580,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10580,1,3,0)
;;=3^Major Neurocog D/O d/t Poss ALZHEIMER'S DISEASE w/ Behav Disturb
;;^UTILITY(U,$J,358.3,10580,1,4,0)
;;=4^F02.81
;;^UTILITY(U,$J,358.3,10580,2)
;;=^5003049
;;^UTILITY(U,$J,358.3,10581,0)
;;=G30.9^^42^472^4
;;^UTILITY(U,$J,358.3,10581,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10581,1,3,0)
;;=3^Alzheimer's Disease,Unspec
;;^UTILITY(U,$J,358.3,10581,1,4,0)
;;=4^G30.9
;;^UTILITY(U,$J,358.3,10581,2)
;;=^5003808
;;^UTILITY(U,$J,358.3,10582,0)
;;=G31.01^^42^472^71
;;^UTILITY(U,$J,358.3,10582,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10582,1,3,0)
;;=3^Pick's Disease
;;^UTILITY(U,$J,358.3,10582,1,4,0)
;;=4^G31.01
;;^UTILITY(U,$J,358.3,10582,2)
;;=^329915
;;^UTILITY(U,$J,358.3,10583,0)
;;=G94.^^42^472^6
;;^UTILITY(U,$J,358.3,10583,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10583,1,3,0)
;;=3^Brain Disorders in Diseases Classified Elsewhere NEC
;;^UTILITY(U,$J,358.3,10583,1,4,0)
;;=4^G94.
;;^UTILITY(U,$J,358.3,10583,2)
;;=^5004187
;;^UTILITY(U,$J,358.3,10584,0)
;;=G31.83^^42^472^18
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0NH 3797 printed Nov 22, 2024@17:02:18 Page 2
IBDEI0NH ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,10572,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,10572,1,3,0)
+4 ;;=3^Bipolar & Related Disorder,Other Specified
+5 ;;^UTILITY(U,$J,358.3,10572,1,4,0)
+6 ;;=4^F31.89
+7 ;;^UTILITY(U,$J,358.3,10572,2)
+8 ;;=^5003520
+9 ;;^UTILITY(U,$J,358.3,10573,0)
+10 ;;=F31.9^^42^471^5
+11 ;;^UTILITY(U,$J,358.3,10573,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,10573,1,3,0)
+14 ;;=3^Bipolar & Related Disorder,Unsp
+15 ;;^UTILITY(U,$J,358.3,10573,1,4,0)
+16 ;;=4^F31.9
+17 ;;^UTILITY(U,$J,358.3,10573,2)
+18 ;;=^331892
+19 ;;^UTILITY(U,$J,358.3,10574,0)
+20 ;;=A81.00^^42^472^8
+21 ;;^UTILITY(U,$J,358.3,10574,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,10574,1,3,0)
+24 ;;=3^Creutzfeldt-Jakob Disease,Unspec
+25 ;;^UTILITY(U,$J,358.3,10574,1,4,0)
+26 ;;=4^A81.00
+27 ;;^UTILITY(U,$J,358.3,10574,2)
+28 ;;=^5000409
+29 ;;^UTILITY(U,$J,358.3,10575,0)
+30 ;;=A81.09^^42^472^7
+31 ;;^UTILITY(U,$J,358.3,10575,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,10575,1,3,0)
+34 ;;=3^Creutzfeldt-Jakob Disease,Other
+35 ;;^UTILITY(U,$J,358.3,10575,1,4,0)
+36 ;;=4^A81.09
+37 ;;^UTILITY(U,$J,358.3,10575,2)
+38 ;;=^5000410
+39 ;;^UTILITY(U,$J,358.3,10576,0)
+40 ;;=A81.2^^42^472^73
+41 ;;^UTILITY(U,$J,358.3,10576,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,10576,1,3,0)
+44 ;;=3^Progressive Multifocal Leukoencephalopathy
+45 ;;^UTILITY(U,$J,358.3,10576,1,4,0)
+46 ;;=4^A81.2
+47 ;;^UTILITY(U,$J,358.3,10576,2)
+48 ;;=^5000411
+49 ;;^UTILITY(U,$J,358.3,10577,0)
+50 ;;=F01.50^^42^472^47
+51 ;;^UTILITY(U,$J,358.3,10577,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,10577,1,3,0)
+54 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/o Behav Disturb
+55 ;;^UTILITY(U,$J,358.3,10577,1,4,0)
+56 ;;=4^F01.50
+57 ;;^UTILITY(U,$J,358.3,10577,2)
+58 ;;=^5003046
+59 ;;^UTILITY(U,$J,358.3,10578,0)
+60 ;;=F01.51^^42^472^48
+61 ;;^UTILITY(U,$J,358.3,10578,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,10578,1,3,0)
+64 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/ Behav Disturb
+65 ;;^UTILITY(U,$J,358.3,10578,1,4,0)
+66 ;;=4^F01.51
+67 ;;^UTILITY(U,$J,358.3,10578,2)
+68 ;;=^5003047
+69 ;;^UTILITY(U,$J,358.3,10579,0)
+70 ;;=F02.80^^42^472^35
+71 ;;^UTILITY(U,$J,358.3,10579,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,10579,1,3,0)
+74 ;;=3^Major Neurocog D/O d/t Poss ALZHEIMER'S DISEASE w/o Behav Disturb
+75 ;;^UTILITY(U,$J,358.3,10579,1,4,0)
+76 ;;=4^F02.80
+77 ;;^UTILITY(U,$J,358.3,10579,2)
+78 ;;=^5003048
+79 ;;^UTILITY(U,$J,358.3,10580,0)
+80 ;;=F02.81^^42^472^36
+81 ;;^UTILITY(U,$J,358.3,10580,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,10580,1,3,0)
+84 ;;=3^Major Neurocog D/O d/t Poss ALZHEIMER'S DISEASE w/ Behav Disturb
+85 ;;^UTILITY(U,$J,358.3,10580,1,4,0)
+86 ;;=4^F02.81
+87 ;;^UTILITY(U,$J,358.3,10580,2)
+88 ;;=^5003049
+89 ;;^UTILITY(U,$J,358.3,10581,0)
+90 ;;=G30.9^^42^472^4
+91 ;;^UTILITY(U,$J,358.3,10581,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,10581,1,3,0)
+94 ;;=3^Alzheimer's Disease,Unspec
+95 ;;^UTILITY(U,$J,358.3,10581,1,4,0)
+96 ;;=4^G30.9
+97 ;;^UTILITY(U,$J,358.3,10581,2)
+98 ;;=^5003808
+99 ;;^UTILITY(U,$J,358.3,10582,0)
+100 ;;=G31.01^^42^472^71
+101 ;;^UTILITY(U,$J,358.3,10582,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,10582,1,3,0)
+104 ;;=3^Pick's Disease
+105 ;;^UTILITY(U,$J,358.3,10582,1,4,0)
+106 ;;=4^G31.01
+107 ;;^UTILITY(U,$J,358.3,10582,2)
+108 ;;=^329915
+109 ;;^UTILITY(U,$J,358.3,10583,0)
+110 ;;=G94.^^42^472^6
+111 ;;^UTILITY(U,$J,358.3,10583,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,10583,1,3,0)
+114 ;;=3^Brain Disorders in Diseases Classified Elsewhere NEC
+115 ;;^UTILITY(U,$J,358.3,10583,1,4,0)
+116 ;;=4^G94.
+117 ;;^UTILITY(U,$J,358.3,10583,2)
+118 ;;=^5004187
+119 ;;^UTILITY(U,$J,358.3,10584,0)
+120 ;;=G31.83^^42^472^18
